B.A. in Biology, 1989
University of Kansas, Lawrence, Kansas
University of Texas Health Science Center, Houston, Texas
Residency in General Psychiatry, 1998
University of Texas Medical Branch, Galveston, Texas
Fellowship in Forensic Psychiatry, 1999
University of Texas Southwestern Medical School, Dallas, Texas
Diplomate in the specialty of Psychiatry by the American Board of Psychiatry and Neurology
Since 1999, Dr. Slaughter has been in private practice in Collin County, Texas.
I treat adult patients suffering from mood and anxiety problems, as well as other psychiatric conditions. After an extensive evaluation, I spend time with each patient in order to develop a personalized plan to address each area of concern. I utilize various treatment modalities, including medications, psychotherapy, and other evidence based interventions. For patients suffering from substance use issues, I am also the medical director for an outpatient substance abuse treatment center and can coordinate care for patients needing those services.
TMS Neuro Solutions will be joining me in my new location as well. I will now be able to provide TMS Therapy and Digital Neuro Evaluations to patients. TMS Therapy is FDA approved for depression, a safe and effective treatment for those that have not seen enough improvement with medication alone, or cannot tolerate the side effects from medication. The Digital Neuro Evaluation allows me to measure your brain function to better understand memory loss, cognitive impairment, and other stress related issues.
I am trained in both general and forensic psychiatry. I assess and treat adult patients with many different conditions, primarily related to mood and anxiety. I use treatment and health interventions to help patients become more resilient and able to live healthier and happier lives.
Our practice can provide psychiatric evaluation, counseling, medications, genetic testing, substance abuse treatment, forensic (legal) evaluations and we’ve recently added Transcranial Magnetic Stimulation (TMS) to help treatment resistant patients with Major Depression.”